Innovation in the iot e-health sector Spain

, , , ,
Integral service around a transaction
BY : Diego GutiérrezJuly Fri, 2016
The internet of things has reached Spanish healthcare. Several Spanish startups such as Social Diabetes, Dycare or Exotive are succeeding and winning awards in the sector. Some of these companies have become what they are thanks to public funding.
Spanish IoT e-health company with a promising future
Social Diabetes

 Social Diabetes is a blood glucose self-monitoring application capable of adjusting insulin dosage at any given time in real time and quantifying carbohydrate intake and exercise that runs on multiple devices and platforms and connects to the cloud with full freedom of data access while maintaining a continuous record of data.

The app has won numerous awards and has received two small rounds of funding amounting to €300,000, one in 2013, a year after its creation, and another in 2015.

Social Diabetes has recently developed an application together with the Basque company Nire iHealth and the Hospital Clínico San Carlos in Madrid, which was selected as a finalist in the Best M-Government Service Award competition organised by the Government of the United Arab Emirates.

Dycare, wearables for injury rehabilitation

Dycare is a Catalan company that has developed a device to analyse the movement of human joints through wearable sensors that are placed on the area to be studied. Thanks to this wearable, the doctor can apply a more personalised treatment and see the evolution of the patient.

Dycare is not yet on the market, but they hope to bring the product to market soon, once the relevant quality certifications have been obtained.

Dycare has so far obtained an Enisa loan for young entrepreneurs of 40,000 euros. It has also received support from the pharmaceutical company Bayer, which provided them with the use of coworking facilities and made available specialists in mentoring and coaching for 6 months. It has also received €50,000 in European funding through the SME instrument. It is now looking to close a funding round in order to move forward with the development of new products.


Exovite  manufactures 3D splints to replace the classic plaster cast. His system first scans the patient's limb and then creates the splint with a 3D printer. The splint can get wet, and because it can be printed with windows, if the patient has wounds it can heal. The system is also pioneering at the rehabilitation level. Thanks to an app (connected to the doctor) and the windows of the splint, the patient can use electrostimulators without going to the medical centre.

Exovite is one of the 11 companies selected worldwide and the first Spanish company (among 300 applicants worldwide) to participate in the Microsoft acceleration programme in the Israeli city of Tel-Aviv. In addition, in the I Ibero-American Campus Etopia, Exovite won the prize for the most innovative project with less than three years of life and the prize chosen by the participants themselves.


 QuBiotech is a start-up a biotech company dedicated to the development of new techno-informatics tools for processing and analysing medical images. Its first product, IQ-brain, is an online tool designed to complement visual image analysis, increasing safety in the diagnosis of neurological diseases.

The company was founded in 2014 and has received numerous awards in its barely two years of existence, including the 2014 Bioga Award for Best Business Idea and the award for Best Young Company granted by the University of Santiago in June 2015 as part of the Uniemprende business creation programme.

Furthermore, in May QuBiotech was selected to attend Health 2.0 Europe, the largest European trade fair in the digital health sector, where projects are exhibited to more than 40 investors from all over the world specialised in the sector.

Public funding to finance innovation

 For some of the companies mentioned above, public funding has been essential to get them to where they are today, including the aid they have received:

EnisaDycare received €400,000 from Enisa's young entrepreneurs line. The aim of this aid is to provide the necessary financial resources to newly established SMEs created by young people, so that they can undertake the investments required by the project in its initial phase.

SME Instrument H2020SME Facility: This is a phased grant funding scheme aimed at supporting SMEs, which have the ambition to grow, develop and internationalise through an innovation project with a European dimension. Dycare has also obtained an SME Instrument.

Navarre Entrepreneurial Impulse ActionImpulso Emprendedor", promoted by the  Government of Navarreoffers entrepreneurs a comprehensive four-month programme for the creation of companies to activate the development and start-up of their business initiatives. Exovite participated in the second edition.



If you are looking for funding in the e-health sector or would like to enter the sector, please contact us, call us on +34 946424142 or fill in the contact form.

The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?